Earlier today the US House of Representatives passed a 12 bill spending package that includes a provision prohibiting the FDA from enforcing regulations against premium cigars. The bill, known as an omnibus appropriations package, passed the House by 211-198 votes and will now move to the Senate for consideration. Congress has until December 8th to pass spending legislation and fund the federal government.
Yesterday Congressman Bill Posey (R-FL) testified before the House Appropriations Subcommittee on Agriculture about the need for appropriations language exempting premium cigars from the FDA’s deeming rule. This testimony came during the Appropriations Committee’s annual members’ day. IPCPR applauds Congressman Posey and extends our thanks on behalf of premium cigar retailers and tobacconists across the country for his continued fight for premium cigars and individual liberty.
EASTON, PA--(Marketwired - March 30, 2017) - Famous Smoke Shop, the leading online distributor of discounted premium cigars, has debuted their new interactive Cigar Smokers' Rights Hub. Crafted in response to the US Food & Drug Administration's 2016 Final Deeming Rule regarding premium cigars and other tobacco products, the Famous Smoke guide presents cigar enthusiasts with a history of legal actions affecting the tobacco industry. The Smokers' Rights Hub also offers cigar smokers a detailed understanding of how FDA's new regulations will negatively impact the premium cigar industry, and the legal challenges that have been mounted against the agency's sweeping new rules.
FOR IMMEDIATE RELEASE - July 28, 2017 - WASHINGTON, D.C. - Today, Commissioner of the U.S. Food & Drug Administration, Dr. Scott Gottlieb, announced a new comprehensive plan for the approach the agency will take to the regulation of tobacco products, placing an emphasis on a science-based method, that notes a "continuum of risk" that recognizes the differences in tobacco products.
FDA Issues Deeming Regulation on Tobacco Products On April 24, 2014, the U.S. Food and Drug Administration (FDA) released proposed regulations...
Earlier today the United States Senate confirmed Dr. Scott Gottlieb as the next Commissioner of the Food & Drug Administration (FDA). IPCPR applauds the Senate’s decision to put thoughtful and experienced leadership at the head of an organization as critical as the FDA. Dr. Gottlieb’s confirmation puts a reform minded physician with experience in both the public and private sectors in charge of a regulatory body that has too often failed in its mission to protect the public health without needlessly hampering commerce in this country. The small business retailers and professional tobacconists that make up IPCPR are counting on the leadership of Dr. Gottlieb and the actions of his FDA to address and correct the onerous and catastrophic elements of last year’s Deeming Rule.
This week the FDA announced a six-month extension of the ingredient listing requirement for manufacturers and importers of newly “deemed”...
The Premium Cigar Industry had a huge victory in the area of cigar regulation. In perhaps the biggest news since the deeming regulations were announced in 2016, those rules have now been completely vacated by the FDA. The ruling means that the deeming regulations introduced by the agency in 2016 do not apply to any cigar that meets the court’s definition of “premium cigar,” meaning that those cigars are unregulated in the U.S.
Today President Trump announced Dr. Scott Gottlieb as his pick to lead the Food & Drug Administration (FDA). Dr. Gottlieb has an impressive and extensive resume, with a wide-ranging background in both the private and public sectors and a M.D. from Mount Sinai School of Medicine. IPCPR welcomes the pick of Dr. Gottlieb and, If confirmed, we look forward to working with him as we continue to advocate for common-sense reforms to the recent FDA regulation needlessly harming the family owned small businesses retailers that make up IPCPR.
The U.S. Food and Drug Administration on Thursday decided to choose Option 1 of the two proposed regulations on tobacco products, option 2 would have granted an exemption for premium cigars. Today, the FDA banned sales of e-cigarettes, cigars, pipe tobacco and hookah tobacco to people under age 18, in line with cigarette rules, a move aimed at preventing a new generation from becoming addicted to nicotine. The agency said it also will require companies to submit these products to it for regulatory review, provide it with a list of product ingredients and place health warnings on their product packages and in advertisements.